Reflux inhibitor drugs: An emerging novel therapy for gastroesophageal reflux disease

被引：9
作者：
Dent, John [1 ,2 ]
机构：
[1] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Adelaide, SA, Australia
来源：
JOURNAL OF DIGESTIVE DISEASES | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1111/j.1751-2980.2010.00418.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：72 / 75
页数：4
相关论文
共 13 条
[1]   Does the Presence of a Hiatal Hernia Affect the Efficacy of the Reflux Inhibitor Baclofen During Add-On Therapy? [J].
Beaumont, Hanneke ;
Boeckxstaens, Guy E. E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (07) :1764-1771
[2]   Emerging drugs for gastroesophageal reflux disease [J].
Boeckxstaens, G. E. .
EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (03) :481-491
[3]  
Boeckxstaens GE, 2009, GASTROENTEROLOGY, V136, pA436
[4]   Pathogenesis of gastro-oesophageal reflux disease and novel options for its therapy [J].
Dent, J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 :91-102
[5]   MECHANISM OF GASTROESOPHAGEAL REFLUX IN RECUMBENT ASYMPTOMATIC HUMAN-SUBJECTS [J].
DENT, J ;
DODDS, WJ ;
FRIEDMAN, RH ;
SEKIGUCHI, T ;
HOGAN, WJ ;
ARNDORFER, RC ;
PETRIE, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (02) :256-267
[6]   Heartburn, treatment in primary care: randomised, double blind study for 8 weeks [J].
Hatlebakk, JG ;
Hyggen, A ;
Madsen, PH ;
Walle, PO ;
Schulz, T ;
Mowinckel, P ;
Bernklev, T ;
Berstad, A .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7209) :550-553
[7]   A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease [J].
Keywood, C. ;
Wakefield, M. ;
Tack, J. .
GUT, 2009, 58 (09) :1192-1199
[8]   Activation of the GABAB receptor inhibits transient lower esophageal sphincter relaxations in dogs [J].
Lehmann, A ;
Antonsson, M ;
Bremner-Danielsen, M ;
Flärdh, M ;
Hansson-Brändén, L ;
Kärrberg, L .
GASTROENTEROLOGY, 1999, 117 (05) :1147-1154
[9]   (R)-(3-Amino-2-fluoropropyl) Phosphinic Acid (AZD3355), a Novel GABAB Receptor Agonist, Inhibits Transient Lower Esophageal Sphincter Relaxation through a Peripheral Mode of Action [J].
Lehmann, Anders ;
Antonsson, Madeleine ;
Holmberg, Ann Aurell ;
Blackshaw, L. Ashley ;
Branden, Lena ;
Braeuner-Osborne, Hans ;
Christiansen, Bolette ;
Dent, John ;
Elebring, Thomas ;
Jacobson, Britt-Marie ;
Jensen, Jorgen ;
Mattsson, Jan P. ;
Nilsson, Karolina ;
Oja, Simo S. ;
Page, Amanda J. ;
Saransaari, Pirjo ;
von Unge, Sverker .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02) :504-512
[10]   TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATION [J].
MITTAL, RK ;
HOLLOWAY, RH ;
PENAGINI, R ;
BLACKSHAW, LA ;
DENT, J .
GASTROENTEROLOGY, 1995, 109 (02) :601-610
12